STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

PTC Therapeutics (NASDAQ: PTCT) will host a webcast conference call to report third quarter 2025 financial results and provide a business outlook on Tuesday, November 4, 2025 at 4:30 p.m. ET.

Participants can register for phone access to receive dial-in details and are advised to dial in 15 minutes early. The live webcast will be available in the Investors section at https://ir.ptcbio.com/events-presentations. A replay will be posted about two hours after the call and will remain archived on the company website for 30 days.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-1.74% News Effect
+16.7% Peak Tracked
-$94M Valuation Impact
$5.34B Market Cap
0.7x Rel. Volume

On the day this news was published, PTCT declined 1.74%, reflecting a mild negative market reaction. Argus tracked a peak move of +16.7% during that session. This price movement removed approximately $94M from the company's valuation, bringing the market cap to $5.34B at that time.

Data tracked by StockTitan Argus on the day of publication.

WARREN, N.J., Oct. 21, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its third quarter 2025 financial results and provide an update on the company's business and outlook on Tuesday, November 4, at 4:30 p.m. ET.

To access the call by phone, please click here to register, and you will be provided with dial-in details. To avoid delays, we recommend that participants dial in for the conference call 15 minutes before the start of the call. The webcast conference call can be accessed on the Investors section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.

ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow on Facebook, X, and LinkedIn.

For more information, please contact:

Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-third-quarter-2025-financial-results-302589963.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics (PTCT) report third quarter 2025 results?

PTC will report on Tuesday, November 4, 2025 at 4:30 p.m. ET via webcast and phone call.

How can I join the PTCT Q3 2025 earnings call by phone?

Register via the company link to receive dial-in details and plan to dial in 15 minutes before the 4:30 p.m. ET start.

Where will the PTCT Q3 2025 webcast be available?

The live webcast will be on PTC Therapeutics' Investors page at https://ir.ptcbio.com/events-presentations.

When will the replay of the PTCT November 4, 2025 call be available?

A replay will be available approximately two hours after the call and archived for 30 days on the company website.

What will PTC Therapeutics (PTCT) cover on the November 4, 2025 call?

The company will report its third quarter 2025 financial results and provide an update on business and outlook.
Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

6.17B
78.27M
2.47%
101.79%
8.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN